Effect of Norathyriol on Uric Acid Excretion Indicators in Hyperuricemic Nephropathy Rats

Ping-fen YANG; Hua LIN; Li-hui GAO; Ling LI; Meng-wei CHENG; Juan YANG; Ge WANG; Yan-fen NIU

doi:10.12259/j.issn.2095-610X.S20210633

Volume 42 Issue 6

Jul. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2021 > 42(6): 16-21

Ping-fen YANG, Hua LIN, Li-hui GAO, Ling LI, Meng-wei CHENG, Juan YANG, Ge WANG, Yan-fen NIU. Effect of Norathyriol on Uric Acid Excretion Indicators in Hyperuricemic Nephropathy Rats[J]. Journal of Kunming Medical University, 2021, 42(6): 16-21. doi: 10.12259/j.issn.2095-610X.S20210633

Citation:

Ping-fen YANG, Hua LIN, Li-hui GAO, Ling LI, Meng-wei CHENG, Juan YANG, Ge WANG, Yan-fen NIU. Effect of Norathyriol on Uric Acid Excretion Indicators in Hyperuricemic Nephropathy Rats[J]. Journal of Kunming Medical University, 2021, 42(6): 16-21. doi: 10.12259/j.issn.2095-610X.S20210633

Citation:

Ping-fen YANG, Hua LIN, Li-hui GAO, Ling LI, Meng-wei CHENG, Juan YANG, Ge WANG, Yan-fen NIU. Effect of Norathyriol on Uric Acid Excretion Indicators in Hyperuricemic Nephropathy Rats[J]. Journal of Kunming Medical University, 2021, 42(6): 16-21. doi: 10.12259/j.issn.2095-610X.S20210633

PDF( 619 KB)

Effect of Norathyriol on Uric Acid Excretion Indicators in Hyperuricemic Nephropathy Rats

doi: 10.12259/j.issn.2095-610X.S20210633

Biomedical Engineering Research Center of Kunming Medical University，Kunming Yunnan 650500，China

Received Date: 2021-03-18
Available Online: 2021-07-03
Publish Date: 2021-07-21

Abstract

Abstract

Objective To study the effect of norathyriol on uric acid excretion indicators in hyperuricemic nephropathy （HN） rats induced by adenine and potassium oxazinate. Method Sixty male SD rats were randomly divided into normal group, model group, norathyriol 1.0, 2.0, 4.0 mg/kg group, positive control benzbromarone 12.5 mg/kg group, each group of 10, according to 20 mL/kg volume were given respectively adenine （0.1 g/kg） and potassium oxonate （1.5 g/kg） suspension after 1 hour, and according to 10 ml/kg volume were given the test drug was administered once a day for 28 days. The gain weight of the rats was monitored weekly, and the urine was collected for 24 hours in themetabolic cage at 7, 14, 21 and 28 days after the administration. The urine volume, urine uric acid and urine creatinine were measured. At the end of the experiment, blood uric acid, serum creatinine and organ weight were measured. Uric acid excretion indicators were calculated: The fractional excretion of uric acid （FEUA）, the amount of 24 h uric acid excretion （24 h U_UA）, creatinine clearance （C_Cr）, uric acid clearance （Cur）, glomerular load of uric acid （FLur）, excretion of uric acid per volume of glomerular filtration （EurGF） and ratio of urinary uric acid to creatinine. Results Norathyriol groups significantly reduced the level of serum uric acid in rats with hyperuricemic nephropathy. After 7 days of administration of 2.0 mg/kg norathyriol, 24 h UUA significantly increased （P < 0.05）. After 14 days and 28 days of administration of 2.0 mg/kg norathyriol, FEUA and Cur significantly increased （P < 0.05, P < 0.01）. Conclusion Norathyriol could affect FEUA and Cur, the sensitive indicators of uric acid excretion of rats with hyperuricemic nephropathy.
- Norathyriol,
- Hyperuricemic nephropathy,
- Uric acid excretion indicators,
- Fractional excretion of uric acid,
- Uric acid clearance

FullText(HTML)

References(16)

References

[1]	Conen D,Wietlisbach V,Bovet P,et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country[J]. Bmc Public Health,2004,4(9):1-9.
[2]	Qiu L,Cheng X Q,Wu J,et al. Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces[J]. Bmc Public Health,2013,13(1):664. doi: 10.1186/1471-2458-13-664
[3]	Pascart T,Lioté F. Gout:state of the art after a decade of developments[J]. Rheumatology,2019,58(1):27-44.
[4]	Filiopoulos V,Hadjiyannakos D,Vlassopouls D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease[J]. Ren Fail,2012,34(4):510-520. doi: 10.3109/0886022X.2011.653753
[5]	Badve S V,Brown F,Hawley C M,et al. Challenges of conducting a trial of uric-acid-lowering therapy in CKD[J]. Nat Rev Nephrol,2011,7(5):295-300. doi: 10.1038/nrneph.2010.186
[6]	Gustafsson D,Unwin R. The pathophysiology of hyperuricaemia and its possiblerelationship to cardiovascular disease,morbidity and mortality[J]. BMC Nephrol,2013,14(164):1-9.
[7]	Kang D H,Chen W. Uric acid and chronic kidney disease:new understanding of an old problem[J]. Semin Nephrol,2011,31(5):447-452. doi: 10.1016/j.semnephrol.2011.08.009
[8]	胡文姬,李学坚,刘布鸣,等. 芒果苷苷元研究进展[J]. 时珍国医国药,2013,24(11):2759-2763.
[9]	Niu Y F,Liu J,Liu H Y,et al. Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity[J]. Pharm Biol,2016,54(9):1680-1686. doi: 10.3109/13880209.2015.1120322
[10]	Lin H,Tu C,Niu Y F,et al. Dual actions of norathyriol as a new candidate hypouricaemic agent:uricosuric effects and xanthine oxidase inhibition[J]. Eur J of Pharmacol,2019,853:371-380. doi: 10.1016/j.ejphar.2019.04.034
[11]	Perez-Ruiz F,Calabozo M. García Erauskin G,et al. García Erauskin G,et al. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output[J]. Arthritis Rhum,2002,47(6):610-613. doi: 10.1002/art.10792
[12]	Ali B H,Al Z M,Adham S A,et al. Therapeutic effect of chrysin on adenine-induced chronic kidney disease in rats[J]. Cell Physiol Biochem,2016,38(1):248-257. doi: 10.1159/000438626
[13]	Liu N,Wang L,Yang T,et al. EGF receptor inhibition alleviates hyperuricemic nephropathy[J]. J Am Soc Nephrol,2015,26(11):2716-2729. doi: 10.1681/ASN.2014080793
[14]	张云静,邹作君,于龙丽,等. 早期肾功能损害患者肾脏排泄尿酸各指标的比较与分析[J]. 中国中西医结合肾病杂志,2012,13(1):54-56. doi: 10.3969/j.issn.1009-587X.2012.01.017
[15]	Wang C P,Wang X,Zhang X,et al. Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice[J]. J Pharm Pharm Sci,2010,13(3):411-427. doi: 10.18433/J3Q30H
[16]	Wortmann R L,Fox I H. Limited value of uric acid to creatinine ratios in estimating uric acid excretion[J]. Ann Intern Med,1980,93(6):822-825. doi: 10.7326/0003-4819-93-6-822

Relative Articles(20)

Relative Articles

[1]	Xin CHEN, Zhijiang DING, Lei LI, Huayou LUO, Guoping LI. Research Progress on the Correlation between Serum Uric Acid and Head and Neck Tumors. Journal of Kunming Medical University, 2025, 46(9): 152-158. doi: 10.12259/j.issn.2095-610X.S20250918
[2]	Yajie SHEN, Yali YANG, Zhiqing YU, Cheng QIAO. A Survey on the Prevalence of Hyperuricemia among Ethnic Minorities in Gongshan County，Yunnan Province. Journal of Kunming Medical University, 2025, 46(3): 39-43. doi: 10.12259/j.issn.2095-610X.S20250307
[3]	Ling NIU, Boyi LI, Cuijuan MIAO, Cheng ZHANG, Yan TANG, Fang LIU, Rong MA. Relationship between Leptin，Uric Acid，and Obesity in Type 2 Diabetes Mellitus. Journal of Kunming Medical University, 2023, 44(11): 140-144. doi: 10.12259/j.issn.2095-610X.S20231121
[4]	Dan LI, Xulian WAN, Lvyu LI, Yu YUN, Guangyun LUO, Weibing LIU, Gongfu LIN, Ning LI, Yongkun LI, Weigang DUAN. Intestinal Flora in Uricase-Deficient Rats. Journal of Kunming Medical University, 2023, 44(2): 27-32. doi: 10.12259/j.issn.2095-610X.S20230205
[5]	Yuanqing CAO, Xiangyu ZI, Yankun ZHU, Baohong YUAN. Studies on the Correlation of Early Blood Uric Acid Fluctuation after Bariatric Surgery. Journal of Kunming Medical University, 2022, 43(9): 53-58. doi: 10.12259/j.issn.2095-610X.S20220924
[6]	Wan QIN, Yalin QI, Yinfang GAO, Nan FAN, Yu YUN, Weigang DUAN. Polyethylene Glycol 4000 Lowers Serum Uric Acid in Uricase-deficient Rats. Journal of Kunming Medical University, 2022, 43(8): 1-6. doi: 10.12259/j.issn.2095-610X.S20220801
[7]	Ai-ping XU, Hua LIN, Li-hui GAO, Ling LI, Meng-wei CHENG, Ge WANG, Juan YANG, Yan-fen NIU. Effect of Norathyriol on the Epithelial-mesenchymal Transition of HK-2 Cells Induced by TGF-β1. Journal of Kunming Medical University, 2021, 42(7): 1-6. doi: 10.12259/j.issn.2095-610X.S20210701
[8]	Li Mei , Xu Wang Bin , Wang Yu Ping , Wang Fei , Dai Dong Mei . . Journal of Kunming Medical University, 2020, 41(03): 62-66.
[9]	Zhang Nan , Hu Xin Yu , Dong Xian Xiang , Duan Wei Gang , Yun Yu . . Journal of Kunming Medical University, 2019, 40(06): 129-134.
[10]	Hu Xin Yu , Zhang Nan , Dong Xian Xiang , Duan Wei Gang , Yun Yu . Update of Treatment for Lowering Serum Urate. Journal of Kunming Medical University, 2019, 40(03): 131-135.
[11]	Chang Wei , Zhang Xue Hui , Wang Yang , Wang Qi , Wang Song Mei , Xu Fang . The Correlation Analysis between Hyperuricemia and Dyslipidemia in Rural Areas, Yunnan Province. Journal of Kunming Medical University, 2018, 39(06): 124-127.
[12]	Chang Song Jie . The Clinical Efficacy and Safety of Decreasing Blood Uric Acid by Benzene Bromine Malone in Treatment of Hyperuricemia with Elderly Hypertension and Diabetes Mellitus. Journal of Kunming Medical University,
[13]	Chen Xiao Hong . . Journal of Kunming Medical University,
[14]	Yang Bo . . Journal of Kunming Medical University,
[15]	Wang Hong Xiong . . Journal of Kunming Medical University,
[16]	Wang Guo Liang . . Journal of Kunming Medical University,
[17]	Yang Jing . . Journal of Kunming Medical University,
[18]	Yang Jing . . Journal of Kunming Medical University,
[19]	Li Ling . . Journal of Kunming Medical University,
[20]	Deng Zi Yu . . Journal of Kunming Medical University,